Acrivon Therapeutics ACRV
- ACR-2316 — Small Cell Lung Cancer Phase 2
- ACR-2316 — Non-Small Cell Lung Cancer Phase 2
- ACR-2316 — Endometrial Cancer Phase 1
WEE1 (2 companies · 4 programs)
Companies with an active program directed at WEE1.
Zentalis Pharmaceuticals, Inc. ZNTL
- azenosertib — Ovarian Cancer Phase 3